Differences in survival survival time. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy11

Cell Line, Tumor Cells, Cultured Tumor Cells, Cultured Cell Line Bile Ducts, Intrahepatic Spleen Lymph Nodes Neurons T-Lymphocytes Lung Liver

Organisms9

Mice, Inbred C57BL Mice, Inbred BALB C Mice, Knockout Mice, Nude Mice, Transgenic Mice, Inbred Strains Mice, SCID Rats, Sprague-Dawley Mice, Inbred C3H

Diseases57

Lung Neoplasms Neoplasm Recurrence, Local Adenocarcinoma Brain Neoplasms Liver Neoplasms Neoplasm Metastasis Breast Neoplasms Disease Progression Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Lymphatic Metastasis Glioblastoma Carcinoma, Hepatocellular Carcinoma, Squamous Cell Pancreatic Neoplasms Stomach Neoplasms Disease Models, Animal Carcinoma Ovarian Neoplasms Neoplasms Glioma Recurrence Neoplasm Invasiveness Melanoma Esophageal Neoplasms Bile Duct Neoplasms Bone Neoplasms Carcinoma, Small Cell Kidney Neoplasms Cholangiocarcinoma Multiple Myeloma Prostatic Neoplasms Supratentorial Neoplasms Carcinoma, Renal Cell Postoperative Complications Pleural Neoplasms Colonic Neoplasms Skin Neoplasms Mesothelioma Peritoneal Neoplasms Rectal Neoplasms Head and Neck Neoplasms Neoplasms, Experimental Astrocytoma Lymphoma Sarcoma Osteosarcoma Kidney Failure, Chronic Lymphoma, Non-Hodgkin Leukemia L1210 Leukemia, Myeloid, Acute Dog Diseases Acute Disease Neovascularization, Pathologic Neutropenia Carcinoma, Pancreatic Ductal Lymphoma, Large B-Cell, Diffuse

Chemicals and Drugs54

Antineoplastic Agents Cisplatin Tumor Markers, Biological Fluorouracil Doxorubicin Cyclophosphamide Deoxycytidine Antimetabolites, Antineoplastic Vincristine Paclitaxel Etoposide Antibodies, Monoclonal Leucovorin Dacarbazine Carboplatin Prednisone RNA, Messenger Survival of Motor Neuron 1 Protein Camptothecin Organoplatinum Compounds Taxoids Antineoplastic Agents, Phytogenic Vinblastine Immunosuppressive Agents Proto-Oncogene Proteins Antineoplastic Agents, Alkylating Neoplasm Proteins Methotrexate Nimustine Antibodies, Monoclonal, Humanized Tumor Suppressor Protein p53 Cytarabine Recombinant Proteins Tegafur RNA, Small Interfering Receptor, erbB-2 Ki-67 Antigen Receptor, Epidermal Growth Factor Phosphatidylinositol 3-Kinases Protein-Serine-Threonine Kinases Oxonic Acid Antibiotics, Antineoplastic Vindesine Protein Kinase Inhibitors Survival of Motor Neuron 2 Protein DNA-Binding Proteins Quinazolines Mitomycin Cytokines bcl-X Protein Epirubicin Vascular Endothelial Growth Factor A Oxyquinoline Carmustine

Analytical, Diagnostic and Therapeutic Techniques and Equipment88

Survival Rate Disease-Free Survival Survival Analysis Treatment Outcome Kaplan-Meier Estimate Retrospective Studies Prognosis Neoplasm Staging Antineoplastic Combined Chemotherapy Protocols Proportional Hazards Models Follow-Up Studies Combined Modality Therapy Multivariate Analysis Immunohistochemistry Prospective Studies Drug Administration Schedule Risk Factors Cohort Studies Chemotherapy, Adjuvant Transplantation, Homologous Disease Models, Animal Predictive Value of Tests Remission Induction Registries Risk Assessment Palliative Care Radiotherapy, Adjuvant Actuarial Analysis Neoplasm Transplantation Life Tables Liver Transplantation Reverse Transcriptase Polymerase Chain Reaction Heart Transplantation Radiotherapy Dosage Skin Transplantation Kidney Transplantation Blotting, Western Infusions, Intravenous Gene Expression Profiling Salvage Therapy Analysis of Variance Chemoembolization, Therapeutic Probability Neoadjuvant Therapy Neoplasm Grading SEER Program Hepatectomy Tumor Burden Incidence Clinical Trials as Topic Radiotherapy Xenograft Model Antitumor Assays Cause of Death Chi-Square Distribution Chemoradiotherapy Models, Biological Tissue Array Analysis Transplantation, Heterologous Dose Fractionation Regression Analysis Treatment Failure Randomized Controlled Trials as Topic Neoplasms, Experimental Reoperation Clinical Trials, Phase III as Topic Oligonucleotide Array Sequence Analysis Corneal Transplantation Gastrectomy Immunoenzyme Techniques Immunotherapy Life Expectancy Severity of Illness Index Cranial Irradiation Patient Selection Random Allocation Lymph Node Excision Dose-Response Relationship, Radiation Statistics, Nonparametric Drug Therapy, Combination Bone Marrow Transplantation Injections, Intraperitoneal Models, Statistical Transplantation, Autologous Transfection Cell Count Cardiopulmonary Resuscitation Lethal Dose 50 Administration, Oral

Phenomena and Processes30

Cell Survival Graft Survival Time Factors Apoptosis Signal Transduction Cell Proliferation Graft Rejection Gene Expression Regulation, Neoplastic Mutation Dose-Response Relationship, Drug Drug Resistance, Neoplasm Longevity Probability Cell Death Cell Division Microbial Viability Chi-Square Distribution Tissue Survival Cell Differentiation Phosphorylation Phenotype Gene Expression Up-Regulation Dose-Response Relationship, Radiation Genotype Cell Movement Transfection Cell Count Drug Synergism Lethal Dose 50

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Survival Quality of Life

Humanities1

Quality of Life

Information Science8

Survival Rate Registries Life Tables SEER Program Incidence Cause of Death Life Expectancy Molecular Sequence Data

Named Groups3

Survivors Tissue Donors Infant, Newborn

Health Care38

Survival Rate Disease-Free Survival Survival Analysis Treatment Outcome Kaplan-Meier Estimate Retrospective Studies Proportional Hazards Models Follow-Up Studies Multivariate Analysis Prospective Studies Risk Factors Cohort Studies Age Factors Predictive Value of Tests Registries Risk Assessment Palliative Care Actuarial Analysis Life Tables Analysis of Variance Probability SEER Program Incidence Clinical Trials as Topic Cause of Death Chi-Square Distribution Regression Analysis Treatment Failure Randomized Controlled Trials as Topic Clinical Trials, Phase III as Topic Sex Factors Life Expectancy Severity of Illness Index Patient Selection Random Allocation Dose-Response Relationship, Radiation Statistics, Nonparametric Models, Statistical

Geographicals2

United States Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Survival Rate Cell Survival Disease-Free Survival Survival Analysis Survival Graft Survival Treatment Outcome Kaplan-Meier Estimate Time Factors Retrospective Studies Prognosis Neoplasm Staging Antineoplastic Combined Chemotherapy Protocols Proportional Hazards Models Follow-Up Studies Lung Neoplasms Combined Modality Therapy Antineoplastic Agents Neoplasm Recurrence, Local Apoptosis Adenocarcinoma Brain Neoplasms Cisplatin Multivariate Analysis Tumor Markers, Biological Liver Neoplasms Neoplasm Metastasis Immunohistochemistry Breast Neoplasms Disease Progression Carcinoma, Non-Small-Cell Lung Cell Line, Tumor Fluorouracil Prospective Studies Mice, Inbred C57BL Drug Administration Schedule Risk Factors Signal Transduction Cohort Studies Chemotherapy, Adjuvant Doxorubicin Colorectal Neoplasms Lymphatic Metastasis Cyclophosphamide Glioblastoma Carcinoma, Hepatocellular Carcinoma, Squamous Cell Pancreatic Neoplasms Transplantation, Homologous Age Factors Deoxycytidine Stomach Neoplasms Cell Proliferation Mice, Inbred BALB C Disease Models, Animal Graft Rejection Predictive Value of Tests Carcinoma Ovarian Neoplasms Gene Expression Regulation, Neoplastic Antimetabolites, Antineoplastic Vincristine Neoplasms Glioma Recurrence Cells, Cultured Remission Induction Neoplasm Invasiveness Registries Melanoma Mutation Dose-Response Relationship, Drug Paclitaxel Risk Assessment Palliative Care Radiotherapy, Adjuvant Actuarial Analysis Etoposide Neoplasm Transplantation Life Tables Antibodies, Monoclonal Liver Transplantation Mice, Knockout Reverse Transcriptase Polymerase Chain Reaction Esophageal Neoplasms Bile Duct Neoplasms Bone Neoplasms Heart Transplantation Leucovorin Carcinoma, Small Cell Kidney Neoplasms Dacarbazine Carboplatin Prednisone Radiotherapy Dosage Skin Transplantation Cholangiocarcinoma RNA, Messenger Survival of Motor Neuron 1 Protein Kidney Transplantation

No FAQ available that match "differences in survival survival time"